NASDAQ$KIDS

OrthoPediatrics Corp · Q2 2016 earnings

Q2 2016 earnings · · Investor relations

Headline financials

Total Revenue

$9.67M

No prior period
EPS (adj)

-$0.04

No prior period
Net Income

-$288K

No prior period
Operating Income

-$865K

No prior period
Gross Profit

$6.83M

No prior period
R&D Expense

$589K

No prior period

Revenue & EPS history

OrthoPediatrics · Revenue · Quarterly

$9.67M

Q2 2016
Beat estimate in 9 of 10 quarters(90%)
ActualEstimate

Revenue by segment

OrthoPediatrics · $40M total across 3 segments · Q3 2023

  • Trauma and Deformity
    $28.8M+20.5%
  • Scoliosis
    $10.3M+3.3%
  • Sports Medicine/Other
    $862K-20.1%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

-0.6%

Avg return

Earnings day

-1.0%

Avg return

5 days after

-0.4%

Avg return

30 days after

50%

17 / 34 earnings

Positive

+13.1%

Q2 2022

Best reaction

-13.0%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%+13.7%+14.0%
Q4 2025+8.3%+3.9%-12.8%
Q3 2025-2.6%-3.0%+9.3%
Q1 2025+4.0%+4.6%-4.5%
Q4 2024+11.9%+7.0%-0.8%
Q3 2024-7.8%-16.2%-22.3%
Q2 2024-7.8%-9.0%+3.8%
Q1 2024+5.7%-5.3%-1.9%
Q4 2023+5.4%+1.9%+0.8%
Q3 2023+4.2%-5.1%+8.9%
Q2 2023-4.6%-4.9%-7.2%
Q1 2023-7.5%-8.0%-14.4%
Q4 2022+0.5%+1.7%-0.8%
Q3 2022-13.0%-12.4%+0.8%
Q2 2022+13.1%+19.2%-0.8%
Q1 2022-10.2%-17.7%-8.1%
Q4 2021-5.8%-6.3%-2.0%
Q3 2021+2.0%+0.4%-19.4%
Q2 2021+6.9%+4.5%+9.2%
Q1 2021+10.1%+4.4%+4.4%
Q4 2020-7.1%-8.6%+2.3%
Q3 2020-6.5%+6.5%-2.1%
Q2 2020+4.7%+9.7%-0.6%
Q1 2020+2.8%+4.8%+10.0%
Q4 2019+1.1%-4.5%-19.5%
Q3 2019+5.7%+8.9%+10.6%
Q2 2019-0.2%-1.0%+10.9%
Q1 2019-9.5%-10.3%-8.3%
Q4 2018-4.3%-2.0%-6.2%
Q3 2018-12.5%-16.0%-11.4%
Q2 2018+2.7%+2.7%+23.7%
Q1 2018-1.1%+1.9%+32.0%
Q4 2017-1.9%+3.4%-2.9%
Q3 2017-11.3%-2.0%-8.5%
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q1 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro